To answer jason_sac26's question specifically:
From a clinical standpoint, GLP-1 and beta-cell is well-supported by the literature.
The short answer: follow the standard titration protocol and reassess at 4-6 weeks.
The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.
Same experience here with GLP-1 and beta-cell. MASHdoc_SA described it perfectly.
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on GLP-1 and beta-cell.
To answer steph_laguna: I get my labs done through Quest every 3 months.
Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference Standardstane_welly said:MASHdoc_SA described it perfectly
This is exactly right. tane_welly articulated what I have been trying to explain to my doctor for months. The GLP-1 and beta-cell aspect is the most important factor.